Fiona Cheshire BA (Hons)
Strengths
 A highly skilled pharmaceutical representative
 Adept at building strong and successful customer relationships
 Skilled at identifying and delivering business opportunities
 Tenacious, energetic and self motivated
 Proven track record in achieving and exceeding targets
 Able contributor and driver in a team environment
 Strong and effective communicator
 Determined and assertive, particularly working through unprecedented customer
disapproval of the withdrawal of Clarytin
Experience
Bayer
March 12- Oct 15 General Medicine’s Xarelto GP Medical Representative
 Have exceeded sales target in 2014. 122% YTD, 24% market share
 2015 Sales YTD 111% to target with market share at 26%
 Over the last year I have organised 2 state based RACGP meetings
 Accepted the task of mentoring 2 new colleague’s
 Achieved 58 doctor enrolments into the Xarelto PFP resulting in 101 patient
enrolments
 Built a close and effective partnership with my territory partner recognised with a
nomination for the Collaboration Award for 2014
 Strong communication skills resulting in being chosen as SA trainer for Concur
 Maintained excellent communication with the hospital team throughout
 Building strong productive relationships with other Bayer teams on my territory
 Organised over 20 round table and evening meeting
 Provided continual training/ updates for the Womans Health Team on Xarelto
Jan 08 – March 12 At home for my family
Merck Sharpe & Dohm
July 04 - Jan 08 Chronic Disease Management Coordinator
 Provided a specialised service to selected GPs
 Managed a team of nurses providing health assessments to specific patient
groups. Those we had identified as at risk from Osteoporosis or Cardio Vascular
disease
 Constructed management plans and Team care arrangements for GPs
 Enrolled 1,982 patients in the MdCare program of which 1,221 patients
completed a management plan and/or team care arrangement
 Created a bank of allied health care professionals throughout the Northern
Adelaide region who would work with patients without charging a fee gap.
Resulting in a measurably enhanced patient participation rate
 Achieved 110% of total script target
 Achieved 166% target for Fosamax scripts
 Average script yield per GP was 17.3, National average was 13.9 and SA was 16.2
 Achieved highest average initiation per GP for Fosamax scripts, 12.8 per GP
 Received significantly higher than average positive customer feedback in surveys
carried out by territory reps on the 39 GPs I worked with
 Provided daily feedback to territory representatives and weekly written reports
 Created increased results working intensively with smaller GP groups.
Schering-Plough Hybrid GP / TM Represenative, The senior member of a 5 person sales team with a
April 01 – April 04 territory of 1 major Teaching Hospital, 5 District Generals and 900 Gps.
 Customer base was both GPs and Specialists.
 Looked after 3 District general Hospitals calling on ENT, Respiratory and
Dermatology.
 Consistently exceeded call rate; coverage and frequency of target GPs. In 2003
achieved GP contact rate of 5.5 per day, territory average 4.4 and Regional
average was 4.2
 Portfolio of CVD, respiratory, allergy and dermatology products
 Participated in 3 major product launches, Neoclarityn, Asmanex and Ezetrol
 Innovative in finding new ways to gain access to clients
 Recognised as task driven, achieving 50% of entire team CV audits target.
 Following discontinuation of Clarityn I implemented 8 successful product switch
programs from Clarityn to Neoclarityn
 Performed Territory level liaison with co-promoter, MSD. Coordinating target
lists and chairing weekly meetings.
 Chosen to coach and mentor 3 team members
Innovex UK Member of Quantum, the most successful contract sales team of Innovex UK.
October 97 - April 01
 Worked within dedicated and syndicated sales, demanding flexibility and drive
 Consistently achieved call rate and exceeded meeting targets
 Increased frequency and coverage to target GPs in high potential bricks
 Acquired extensive primary and secondary care experience
 Performed in the cardio-vascular, CNS, pain and respiratory markets
 Achieved Senior Representative status
Greenwich Air
Services USA
March 97 - July 97 Human Resource specialist
 Screened, interviewed and managed new employees
Bristol Myers-Squibb
June 96 - March 97 Medical Representative with permanent status.
Advanced from an initial contract position by quickly achieving set targets
 Achieved success within a sales based, target driven, competitive market
 Delivered increased sales by nurturing strong GP relationships
Innovex UK Medical Representative working with Abbott Laboratories.
October 95 - June 96
 Increased sales and market share by improving frequency to target GPs
 Successfully gained formulary status within two large GP practices.
Brands Electronics Group Coordinator for flexible resourcing and production.
June 94 - October 95
 Achieved a successful balance between client needs and resource flexibility
 Managed discrete projects for major clients such as Motorola and Compaq
Melville Craig Recruitment Consultant, managing an established client portfolio.
1994
 Successfully located and placed personnel to match customer needs.
Education Medicines Australia with distinction
ABPI with distinctions, May 1998
1983 - 1994 BA (Hon’s) Business Studies, Napier University Edinburgh, 1989- 1994
BA placement, Marks & Spencer Management Program, 1993
Referees Available on request
Contact Email fionacheshire2009@gmail.com

FIONA CHESHIRECVOct15

  • 1.
    Fiona Cheshire BA(Hons) Strengths  A highly skilled pharmaceutical representative  Adept at building strong and successful customer relationships  Skilled at identifying and delivering business opportunities  Tenacious, energetic and self motivated  Proven track record in achieving and exceeding targets  Able contributor and driver in a team environment  Strong and effective communicator  Determined and assertive, particularly working through unprecedented customer disapproval of the withdrawal of Clarytin Experience Bayer March 12- Oct 15 General Medicine’s Xarelto GP Medical Representative  Have exceeded sales target in 2014. 122% YTD, 24% market share  2015 Sales YTD 111% to target with market share at 26%  Over the last year I have organised 2 state based RACGP meetings  Accepted the task of mentoring 2 new colleague’s  Achieved 58 doctor enrolments into the Xarelto PFP resulting in 101 patient enrolments  Built a close and effective partnership with my territory partner recognised with a nomination for the Collaboration Award for 2014  Strong communication skills resulting in being chosen as SA trainer for Concur  Maintained excellent communication with the hospital team throughout  Building strong productive relationships with other Bayer teams on my territory  Organised over 20 round table and evening meeting  Provided continual training/ updates for the Womans Health Team on Xarelto Jan 08 – March 12 At home for my family Merck Sharpe & Dohm July 04 - Jan 08 Chronic Disease Management Coordinator
  • 2.
     Provided aspecialised service to selected GPs  Managed a team of nurses providing health assessments to specific patient groups. Those we had identified as at risk from Osteoporosis or Cardio Vascular disease  Constructed management plans and Team care arrangements for GPs  Enrolled 1,982 patients in the MdCare program of which 1,221 patients completed a management plan and/or team care arrangement  Created a bank of allied health care professionals throughout the Northern Adelaide region who would work with patients without charging a fee gap. Resulting in a measurably enhanced patient participation rate  Achieved 110% of total script target  Achieved 166% target for Fosamax scripts  Average script yield per GP was 17.3, National average was 13.9 and SA was 16.2  Achieved highest average initiation per GP for Fosamax scripts, 12.8 per GP  Received significantly higher than average positive customer feedback in surveys carried out by territory reps on the 39 GPs I worked with  Provided daily feedback to territory representatives and weekly written reports  Created increased results working intensively with smaller GP groups. Schering-Plough Hybrid GP / TM Represenative, The senior member of a 5 person sales team with a April 01 – April 04 territory of 1 major Teaching Hospital, 5 District Generals and 900 Gps.  Customer base was both GPs and Specialists.  Looked after 3 District general Hospitals calling on ENT, Respiratory and Dermatology.  Consistently exceeded call rate; coverage and frequency of target GPs. In 2003 achieved GP contact rate of 5.5 per day, territory average 4.4 and Regional average was 4.2  Portfolio of CVD, respiratory, allergy and dermatology products  Participated in 3 major product launches, Neoclarityn, Asmanex and Ezetrol  Innovative in finding new ways to gain access to clients  Recognised as task driven, achieving 50% of entire team CV audits target.  Following discontinuation of Clarityn I implemented 8 successful product switch programs from Clarityn to Neoclarityn  Performed Territory level liaison with co-promoter, MSD. Coordinating target lists and chairing weekly meetings.  Chosen to coach and mentor 3 team members
  • 3.
    Innovex UK Memberof Quantum, the most successful contract sales team of Innovex UK. October 97 - April 01  Worked within dedicated and syndicated sales, demanding flexibility and drive  Consistently achieved call rate and exceeded meeting targets  Increased frequency and coverage to target GPs in high potential bricks  Acquired extensive primary and secondary care experience  Performed in the cardio-vascular, CNS, pain and respiratory markets  Achieved Senior Representative status Greenwich Air Services USA March 97 - July 97 Human Resource specialist  Screened, interviewed and managed new employees Bristol Myers-Squibb June 96 - March 97 Medical Representative with permanent status. Advanced from an initial contract position by quickly achieving set targets  Achieved success within a sales based, target driven, competitive market  Delivered increased sales by nurturing strong GP relationships Innovex UK Medical Representative working with Abbott Laboratories. October 95 - June 96  Increased sales and market share by improving frequency to target GPs  Successfully gained formulary status within two large GP practices. Brands Electronics Group Coordinator for flexible resourcing and production. June 94 - October 95  Achieved a successful balance between client needs and resource flexibility  Managed discrete projects for major clients such as Motorola and Compaq Melville Craig Recruitment Consultant, managing an established client portfolio. 1994  Successfully located and placed personnel to match customer needs. Education Medicines Australia with distinction ABPI with distinctions, May 1998 1983 - 1994 BA (Hon’s) Business Studies, Napier University Edinburgh, 1989- 1994
  • 4.
    BA placement, Marks& Spencer Management Program, 1993 Referees Available on request Contact Email fionacheshire2009@gmail.com